Target intelligence / Profile preview

Glial cells missing transcription factor 1 (GCM1)

Target
GCM1
Molecular classification
Transcription factor
01

Overview

Glial cells missing transcription factor 1 (GCM1) is a DNA-binding transcription factor that is essential for the proper formation and differentiation of specific trophoblast subtypes in the human placenta, mainly syncytiotrophoblast and extravillous trophoblast[1][3][4][5]. GCM1 acts primarily as a master regulator of placental development, controlling a critical balance between cytotrophoblast proliferation and differentiation needed for successful pregnancy and fetal growth. Disruption of GCM1 function leads to impaired placentation, causing pregnancy complications such as preeclampsia and intrauterine growth restriction. GCM1 mediates its functions by binding to a unique DNA recognition site (the GCM-motif) and regulating the expression of key downstream genes, including those involved in trophoblast cell fusion and invasiveness[1][3][5]. It is highly specific to trophoblast cells and is evolutionarily conserved from Drosophila, where the gene was originally described, to humans. GCM1 is not currently considered a direct therapeutic target nor is it targeted by existing drugs[5].

Other names
Chorion-specific transcription factor GCMaGCMAhGCMaGCM motif protein 1Glial cells missing homolog 1chorion-specific transcription factor GCMa
02

Biological functions

Regulation of trophoblast differentiationMaintenance and turnover of trophoblast tissueSyncytiotrophoblast formationExtravillous trophoblast developmentRegulation of cell proliferation and differentiation in placenta
03

Disease associations

Placental insufficiency syndromes (e.g., preeclampsia, intrauterine growth restriction)Cancer (notably placental choriocarcinoma)
04

Safety considerations

Altered GCM1 expression is associated with placental insufficiency syndromes and related obstetrical complications such as preeclampsia and intrauterine growth restriction[1][3].

Beyond the preview

Go deeper on Glial cells missing transcription factor 1 (GCM1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glial cells missing transcription factor 1 (GCM1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call